O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth

Jay Prakash Singh; Kevin Qian; Jeong Sang Lee; Jinfeng Zhou; Xuemei Han; Bichen Zhang; Qunxiang Ong; Weiming Ni; Mingzuo Jiang; Hai Bin Ruan; Min Dian Li; Kaisi Zhang; Zhaobing Ding; Philip Lee; Kamini Singh; Jing Wu; Raimund I. Herzog; Susan Kaech; Hans Guido Wendel; John R. Yates; Weiping Han; Robert S. Sherwin; Yongzhan Nie; Xiaoyong Yang

doi:10.1038/s41388-019-0975-3

O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth

Jay Prakash Singh, Kevin Qian, Jeong Sang Lee, Jinfeng Zhou, Xuemei Han, Bichen Zhang, Qunxiang Ong, Weiming Ni, Mingzuo Jiang, Hai Bin Ruan, Min Dian Li, Kaisi Zhang, Zhaobing Ding, Philip Lee, Kamini Singh, Jing Wu, Raimund I. Herzog, Susan Kaech, Hans Guido Wendel, John R. YatesWeiping Han, Robert S. Sherwin, Yongzhan Nie, Xiaoyong Yang

Physiology

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Abstract

Cancer cells are known to adopt aerobic glycolysis in order to fuel tumor growth, but the molecular basis of this metabolic shift remains largely undefined. O-GlcNAcase (OGA) is an enzyme harboring O-linked β-N-acetylglucosamine (O-GlcNAc) hydrolase and cryptic lysine acetyltransferase activities. Here, we report that OGA is upregulated in a wide range of human cancers and drives aerobic glycolysis and tumor growth by inhibiting pyruvate kinase M2 (PKM2). PKM2 is dynamically O-GlcNAcylated in response to changes in glucose availability. Under high glucose conditions, PKM2 is a target of OGA-associated acetyltransferase activity, which facilitates O-GlcNAcylation of PKM2 by O-GlcNAc transferase (OGT). O-GlcNAcylation inhibits PKM2 catalytic activity and thereby promotes aerobic glycolysis and tumor growth. These studies define a causative role for OGA in tumor progression and reveal PKM2 O-GlcNAcylation as a metabolic rheostat that mediates exquisite control of aerobic glycolysis.

Original language	English (US)
Pages (from-to)	560-573
Number of pages	14
Journal	Oncogene
Volume	39
Issue number	3
DOIs	https://doi.org/10.1038/s41388-019-0975-3
State	Published - Jan 16 2020

Bibliographical note

Funding Information:
Acknowledgements We thank Dr. Jinbo Yang for providing the Flag-PKM2 plasmid and shPKM2 lentivirus. We thank Dr. Julie T. Feld-stein for helping with immunohistochemical analysis of human cancer tissues. We thank Dr. Neeraj Tiwari for helping with sucrose density gradient ultracentrifugation. This work was supported by NIH R01 DK089098, P01 DK057751, Yale Comprehensive Cancer Center Pilot Grant, and American Cancer Society Research Scholar Grant to XY.

Publisher Copyright:
© 2019, The Author(s), under exclusive licence to Springer Nature Limited.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1038/s41388-019-0975-3

Find It

Find It at U of M Libraries

Cite this

Singh, JP, Qian, K, Lee, JS, Zhou, J, Han, X, Zhang, B, Ong, Q, Ni, W, Jiang, M, Ruan, HB, Li, MD, Zhang, K, Ding, Z, Lee, P, Singh, K, Wu, J, Herzog, RI, Kaech, S, Wendel, HG, Yates, JR, Han, W, Sherwin, RS, Nie, Y & Yang, X 2020, 'O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth', Oncogene, vol. 39, no. 3, pp. 560-573. https://doi.org/10.1038/s41388-019-0975-3

@article{aa42b4d006cf460e809c9084d5a1235b,

title = "O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth",

abstract = "Cancer cells are known to adopt aerobic glycolysis in order to fuel tumor growth, but the molecular basis of this metabolic shift remains largely undefined. O-GlcNAcase (OGA) is an enzyme harboring O-linked β-N-acetylglucosamine (O-GlcNAc) hydrolase and cryptic lysine acetyltransferase activities. Here, we report that OGA is upregulated in a wide range of human cancers and drives aerobic glycolysis and tumor growth by inhibiting pyruvate kinase M2 (PKM2). PKM2 is dynamically O-GlcNAcylated in response to changes in glucose availability. Under high glucose conditions, PKM2 is a target of OGA-associated acetyltransferase activity, which facilitates O-GlcNAcylation of PKM2 by O-GlcNAc transferase (OGT). O-GlcNAcylation inhibits PKM2 catalytic activity and thereby promotes aerobic glycolysis and tumor growth. These studies define a causative role for OGA in tumor progression and reveal PKM2 O-GlcNAcylation as a metabolic rheostat that mediates exquisite control of aerobic glycolysis.",

author = "Singh, {Jay Prakash} and Kevin Qian and Lee, {Jeong Sang} and Jinfeng Zhou and Xuemei Han and Bichen Zhang and Qunxiang Ong and Weiming Ni and Mingzuo Jiang and Ruan, {Hai Bin} and Li, {Min Dian} and Kaisi Zhang and Zhaobing Ding and Philip Lee and Kamini Singh and Jing Wu and Herzog, {Raimund I.} and Susan Kaech and Wendel, {Hans Guido} and Yates, {John R.} and Weiping Han and Sherwin, {Robert S.} and Yongzhan Nie and Xiaoyong Yang",

note = "Funding Information: Acknowledgements We thank Dr. Jinbo Yang for providing the Flag-PKM2 plasmid and shPKM2 lentivirus. We thank Dr. Julie T. Feld-stein for helping with immunohistochemical analysis of human cancer tissues. We thank Dr. Neeraj Tiwari for helping with sucrose density gradient ultracentrifugation. This work was supported by NIH R01 DK089098, P01 DK057751, Yale Comprehensive Cancer Center Pilot Grant, and American Cancer Society Research Scholar Grant to XY. Publisher Copyright: {\textcopyright} 2019, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2020",

month = jan,

day = "16",

doi = "10.1038/s41388-019-0975-3",

language = "English (US)",

volume = "39",

pages = "560--573",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth

AU - Singh, Jay Prakash

AU - Qian, Kevin

AU - Lee, Jeong Sang

AU - Zhou, Jinfeng

AU - Han, Xuemei

AU - Zhang, Bichen

AU - Ong, Qunxiang

AU - Ni, Weiming

AU - Jiang, Mingzuo

AU - Ruan, Hai Bin

AU - Li, Min Dian

AU - Zhang, Kaisi

AU - Ding, Zhaobing

AU - Lee, Philip

AU - Singh, Kamini

AU - Wu, Jing

AU - Herzog, Raimund I.

AU - Kaech, Susan

AU - Wendel, Hans Guido

AU - Yates, John R.

AU - Han, Weiping

AU - Sherwin, Robert S.

AU - Nie, Yongzhan

AU - Yang, Xiaoyong

N1 - Funding Information: Acknowledgements We thank Dr. Jinbo Yang for providing the Flag-PKM2 plasmid and shPKM2 lentivirus. We thank Dr. Julie T. Feld-stein for helping with immunohistochemical analysis of human cancer tissues. We thank Dr. Neeraj Tiwari for helping with sucrose density gradient ultracentrifugation. This work was supported by NIH R01 DK089098, P01 DK057751, Yale Comprehensive Cancer Center Pilot Grant, and American Cancer Society Research Scholar Grant to XY. Publisher Copyright: © 2019, The Author(s), under exclusive licence to Springer Nature Limited.

PY - 2020/1/16

Y1 - 2020/1/16

N2 - Cancer cells are known to adopt aerobic glycolysis in order to fuel tumor growth, but the molecular basis of this metabolic shift remains largely undefined. O-GlcNAcase (OGA) is an enzyme harboring O-linked β-N-acetylglucosamine (O-GlcNAc) hydrolase and cryptic lysine acetyltransferase activities. Here, we report that OGA is upregulated in a wide range of human cancers and drives aerobic glycolysis and tumor growth by inhibiting pyruvate kinase M2 (PKM2). PKM2 is dynamically O-GlcNAcylated in response to changes in glucose availability. Under high glucose conditions, PKM2 is a target of OGA-associated acetyltransferase activity, which facilitates O-GlcNAcylation of PKM2 by O-GlcNAc transferase (OGT). O-GlcNAcylation inhibits PKM2 catalytic activity and thereby promotes aerobic glycolysis and tumor growth. These studies define a causative role for OGA in tumor progression and reveal PKM2 O-GlcNAcylation as a metabolic rheostat that mediates exquisite control of aerobic glycolysis.

AB - Cancer cells are known to adopt aerobic glycolysis in order to fuel tumor growth, but the molecular basis of this metabolic shift remains largely undefined. O-GlcNAcase (OGA) is an enzyme harboring O-linked β-N-acetylglucosamine (O-GlcNAc) hydrolase and cryptic lysine acetyltransferase activities. Here, we report that OGA is upregulated in a wide range of human cancers and drives aerobic glycolysis and tumor growth by inhibiting pyruvate kinase M2 (PKM2). PKM2 is dynamically O-GlcNAcylated in response to changes in glucose availability. Under high glucose conditions, PKM2 is a target of OGA-associated acetyltransferase activity, which facilitates O-GlcNAcylation of PKM2 by O-GlcNAc transferase (OGT). O-GlcNAcylation inhibits PKM2 catalytic activity and thereby promotes aerobic glycolysis and tumor growth. These studies define a causative role for OGA in tumor progression and reveal PKM2 O-GlcNAcylation as a metabolic rheostat that mediates exquisite control of aerobic glycolysis.

UR - http://www.scopus.com/inward/record.url?scp=85072049518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072049518&partnerID=8YFLogxK

U2 - 10.1038/s41388-019-0975-3

DO - 10.1038/s41388-019-0975-3

M3 - Article

C2 - 31501520

AN - SCOPUS:85072049518

SN - 0950-9232

VL - 39

SP - 560

EP - 573

JO - Oncogene

JF - Oncogene

IS - 3

ER -

O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this